Provenance du réseau au premier degré de Walter G. Smith
Entité | Type d'entité | Industrie | |
---|---|---|---|
OxaluRx, Inc.
2
| Holding Company | Miscellaneous | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Walter G. Smith via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Chief Tech/Sci/R&D Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Private Equity Investor | |
Washington University in St. Louis | College/University | Corporate Officer/Principal | |
Keel Pharmaceuticals, Inc. | Director/Board Member | ||
ZS PHARMA INC | Pharmaceuticals: Major | Director/Board Member | |
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Medical/Nursing Services | Chief Executive Officer | |
ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | Investment Managers | Private Equity Investor | |
The University of Chicago | College/University | Doctorate Degree | |
Northern Illinois University | College/University | Undergraduate Degree | |
University of Wisconsin | College/University | Graduate Degree | |
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Investment Managers | Private Equity Investor Private Equity Investor | |
The Arthritis Foundation
The Arthritis Foundation Miscellaneous Commercial ServicesCommercial Services Arthritis Foundation provides funds research, advocacy and support services for various kinds of arthritis and related diseases. It offers programs and services including aquatic programs, information about treatment breakthroughs, exercise tips for people with the disease and pain management information. Arthritis Foundation is located in Atlanta, GA. | Miscellaneous Commercial Services | Director/Board Member | |
American Society for Pharmacology & Experimental Therapeutic | Corporate Officer/Principal | ||
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Thoracic Society, Inc. is a professional membership organization for thoracic surgeons. The non-profit company is based in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
Adarza BioSystems, Inc.
Adarza BioSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Adarza BioSystems, Inc. develops and manufacturers a multiplex immunoassay technology that can identify proteins and genetic markers in medical specimens. The firm operates as a medical diagnostics company which also develops a rapid and label-free biological assay platform for measuring clinical and point-of-care samples and also its technology allows hundreds of tests to be run simultaneously on a single chip. The company was founded by Benjamin L. Miller, Randolph R. Henke, Terry Gronwall and Christopher C. Striemer in 2008 and is headquartered in St. Louis, MO. | Electronic Equipment/Instruments | Director/Board Member | |
Searle & Co., Inc.
Searle & Co., Inc. Investment ManagersFinance Searle & Co., Inc. provides investment advisory services. The business continuity plan addresses data back up and recovery, all mission critical systems, financial and operational assessments, alternative communications with customers, employees, regulators, alternate physical location of employees, critical supplier, contractor, bank and counter-party impact, regulatory reporting and assuring their customers prompt access to their funds and securities if they are unable to continue their business. The company was founded in 1982 and is headquartered in Greenwich, CT | Investment Managers | Corporate Officer/Principal | |
OTONOMY | Biotechnology | Director/Board Member | |
G.D. Searle LLC | Corporate Officer/Principal | ||
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Chairman | |
ALLAKOS INC. | Pharmaceuticals: Major | Director/Board Member | |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Good Therapeutics, Inc.
Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Good Therapeutics, Inc. operates as a biotechnology company. It develops "context-dependent" protein drugs that sense biomarkers and respond with a therapeutic activity. The company was founded by John Mulligan in 2016 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Packaged Software | Director/Board Member | |
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bonum Therapeutics, Inc. is a privately held American company that focuses on generating a new class of therapeutics based on a proven technology platform. Bonum Therapeutics is based in an undisclosed location and was founded in 2022 by the Good Therapeutics team. The company's technology utilizes principles of allosteric regulation to create highly active and less toxic medicines, which can be applied to a wide range of therapeutic areas, including oncology, autoimmunity, metabolic disorders, and pain management. The company's molecules combine a sensor component directed against a specific biological marker and a therapeutic component. The company is backed by a group of leading venture investors, including Codon Capital, Roche Venture Fund, RiverVest Venture Partners, 3x5 Partners, Digitalis Ventures, and Vivo Capital. The company was founded by John Mulligan, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Daya CNS LLC
Daya CNS LLC MiscellaneousMiscellaneous Daya CNS LLC develops a related compound for the treatment of neuropathic pain. The company was founded by Vi Rajagopalan and is headquartered in Saint Peters, MO. | Miscellaneous | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 33 |
Suisse | 2 |
Sectorielle
Health Technology | 13 |
Consumer Services | 6 |
Commercial Services | 5 |
Finance | 4 |
Process Industries | 3 |
Opérationnelle
Director/Board Member | 18 |
Corporate Officer/Principal | 9 |
Private Equity Investor | 4 |
Chief Executive Officer | 3 |
Chairman | 2 |
Relations les plus connectées
Insiders | |
---|---|
John McKearn | 25 |
Walter Smith | 12 |
- Bourse
- Insiders
- Walter G. Smith
- Connexions Sociétés